We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
About Biomedical Basics
Biomedical Basics are AI-generated explanations prepared with access to the complete collection, human-reviewed prior to publication. Short and simple, covering biomedical and life sciences fundamentals.
Topics Covered
- Therapeutic window and index
- Effective vs toxic dose
- Patient factors in drug response
- Dosing decisions and monitoring
- Narrow therapeutic index drugs
Talk Citation
(2026, September 30). Therapeutic window and safety margins [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 1, 2026, from https://doi.org/10.69645/NPXW5546.Export Citation (RIS)
Publication History
- Published on September 30, 2026
Financial Disclosures
A selection of talks on Pharmaceutical Sciences
Transcript
Please wait while the transcript is being prepared...
0:00
The topic of therapeutic window
and safety margins will be
explored through the key
pharmacological concepts
of therapeutic window,
therapeutic index,
and safety margin,
explaining how they define
the difference between
effective and toxic
doses of medication.
We will discuss
the importance of
these parameters in
clinical dosing decisions,
especially for drugs with
a narrow therapeutic index
that require careful monitoring.
The presentation will
also address how
patient factors such as age,
genetics, and organ function
affect drug responses
and toxicity risk.
Finally, we will highlight
common drugs with
narrow safety margins and
the practical strategies that
clinicians use to
ensure their safe use.
We'll explore the key concepts
of therapeutic window,
therapeutic index, and safety
margin in pharmacology.
The therapeutic window
is the range of
drug concentrations
where the medicine is
effective without
unacceptable toxicity.
The safety margin refers
to the gap between
the effective dose and where
significant harm occurs.
The therapeutic index is
the ratio of toxic dose,
TD 50 to effective dose, ED 50.
Wider windows and
higher indices indicate
that drugs are safer and
dosing is more flexible.
Let's examine the relationship
between effective
and toxic doses.
Imagine a curve showing
drug dose versus likelihood
of benefit or harm.
The effective dose, ED 50
is where half the population
sees the intended effect.
The toxic dose, TD
50 or LD 50 for